Yapo Thomas Aba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yapo Thomas Aba has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
O. Kra
Département de santé publique et Infectiologie, Université Alassane Ouattara de Bouaké, Côte d'Ivoire, France
2 shared publicationsA. Da Costa
Département de cardiologie, Université JM de Saint-Etienne, Saint-Etienne, France
1 shared publicationA. Fresard
Département d'infectiologie, service des maladies infectieuses, CHU de Saint-Etienne, 42055, Saint-Etienne, France
1 shared publicationA. K. Abalé
Service de pédiatrie médicale, CHU de Treichville, Côte d'Ivoire, France
1 shared publicationA.C. Tanoh
1 shared publicationA.R. Kakou
1 shared publication
Latest Publications
- Open Access
- 1 November 2017
- Vol. 8
Prevalence of malaria and clinical profile of febrile HIV infected patients in three HIV clinics in Ivory Coast
To determine the prevalence and clinical profile of malaria among febrile HIV-infected patients followed up in three HIV clinics in Ivory Coast. A cross-sectional multicentre study was conducted between 2009 and 2010 in the Pneumology Department of Cocody Teaching Hospital in Abidjan, Medical Esperance Centre and the Regional Hospital in San-Pedro. Patients of all ages presenting with fever (rectal or axillary temperature >37,5°C) or a medical history of fever within 72 hrs prior to consultation were included. Parasitological diagnostic methods used were microscopy by blood smear (BS) for search malaria parasite and parasite density. Haemoglobin levels were assessed to assess anaemia. Over the study period, 530 people living with HIV consulted for fever. The 476 patients included were predominantly female (n=280, 59%), with a median age of 34 (range 3-74 yrs), a mean of 38 ± 8.3 (SD) yrs, infected with HIV-1 (n=409, 86%), on antiretroviral therapy (n=376, 79%), and cotrimoxazole prophylaxis (n=381, 80%). Only 73 (15%) patients were using LLINs. Malaria prevalence was 10% (n=47). Plasmodium falciparum was the only species identified with a mean density of 15 900 trophozoites/μl. Malaria was more common among patients with a CD4 count of 3 (p<0.001) neither on cotrimoxazole prophylaxis (p<0.001) nor on antiretroviral therapy (ART) (p<0.001). Uncomplicated malaria accounted for 32 (68%) of the cases. The signs of severe malaria (n=15, 32%,) were dominated by severe anaemia (n= 12, 25.5%). Our study revealed that malaria prevalence appears to be low in HIV clinics for people living with HIV on HAART and cotrimoxazole prophylaxis. Uncomplicated malaria is predominant when consultation is early. Signs of severe malaria were dominated by severe anaemia.
- 1 November 2017
- Vol. 8
Open AccessPrevalence of malaria and clinical profile of febrile HIV infected patients in three HIV clinics in Ivory Coast
To determine the prevalence and clinical profile of malaria among febrile HIV-infected patients followed up in three HIV clinics in Ivory Coast. A cross-sectional multicentre study was conducted between 2009 and 2010 in the Pneumology Department of Cocody Teaching Hospital in Abidjan, Medical Esperance Centre and the Regional Hospital in San-Pedro. Patients of all ages presenting with fever (rectal or axillary temperature >37,5°C) or a medical history of fever within 72 hrs prior to consultation were included. Parasitological diagnostic methods used were microscopy by blood smear (BS) for search malaria parasite and parasite density. Haemoglobin levels were assessed to assess anaemia. Over the study period, 530 people living with HIV consulted for fever. The 476 patients included were predominantly female (n=280, 59%), with a median age of 34 (range 3-74 yrs), a mean of 38 ± 8.3 (SD) yrs, infected with HIV-1 (n=409, 86%), on antiretroviral therapy (n=376, 79%), and cotrimoxazole prophylaxis (n=381, 80%). Only 73 (15%) patients were using LLINs. Malaria prevalence was 10% (n=47). Plasmodium falciparum was the only species identified with a mean density of 15 900 trophozoites/μl. Malaria was more common among patients with a CD4 count of 3 (p<0.001) neither on cotrimoxazole prophylaxis (p<0.001) nor on antiretroviral therapy (ART) (p<0.001). Uncomplicated malaria accounted for 32 (68%) of the cases. The signs of severe malaria (n=15, 32%,) were dominated by severe anaemia (n= 12, 25.5%). Our study revealed that malaria prevalence appears to be low in HIV clinics for people living with HIV on HAART and cotrimoxazole prophylaxis. Uncomplicated malaria is predominant when consultation is early. Signs of severe malaria were dominated by severe anaemia.
- 25 September 2017
- Published by Lavoisier in Bulletin de la Société de pathologie exotique
- Vol. 110 (4) , 250-253
Syndrome de Brugada révélé par une shigellose intestinale chez un patient originaire du Bénin au CHU de Saint-Etienne
Cet article présente un cas clinique de syndrome de Brugada (SB) de découverte fortuite au cours d’un épisode fébrile de shigellose intestinale chez un patient originaire du Bénin, hospitalisé dans le service d’infectiologie du CHU de Saint-Etienne en France. Les auteurs établissent le lien entre ces deux affections. Après une revue de la littérature, ils constatent que le SB est sous-estimé voire méconnu en Afrique. Ils rappellent certaines particularités socio-culturelles de la mort subite en Afrique de l’Ouest qui pourraient être provoquées par un SB fatal. This paper is about a Brugada syndrome (BS) of accidental discovery in a patient from Benin during an intestinal shigellosis episode in the infectiology department of university hospital of Saint-Etienne, France. Authors establish a link between these two diseases. After a literature’s review, they underline that BS is under-diagnosed in Africa. Furthermore, they highlight socio-cultural characteristics of sudden deaths in West Africa including BS.
- 25 September 2017
- Published by Lavoisier in Bulletin de la Société de pathologie exotique
- Vol. 110 (4) , 250-253
Syndrome de Brugada révélé par une shigellose intestinale chez un patient originaire du Bénin au CHU de Saint-Etienne
Cet article présente un cas clinique de syndrome de Brugada (SB) de découverte fortuite au cours d’un épisode fébrile de shigellose intestinale chez un patient originaire du Bénin, hospitalisé dans le service d’infectiologie du CHU de Saint-Etienne en France. Les auteurs établissent le lien entre ces deux affections. Après une revue de la littérature, ils constatent que le SB est sous-estimé voire méconnu en Afrique. Ils rappellent certaines particularités socio-culturelles de la mort subite en Afrique de l’Ouest qui pourraient être provoquées par un SB fatal. This paper is about a Brugada syndrome (BS) of accidental discovery in a patient from Benin during an intestinal shigellosis episode in the infectiology department of university hospital of Saint-Etienne, France. Authors establish a link between these two diseases. After a literature’s review, they underline that BS is under-diagnosed in Africa. Furthermore, they highlight socio-cultural characteristics of sudden deaths in West Africa including BS.
- Open Access
- 3 January 2017
- Published by Springer Nature in Malaria Journal
- Vol. 16 (1) , 8
Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d’Ivoire
In many malaria-endemic, sub-Saharan African countries, existing pharmacovigilance systems are not sufficiently operational to document reliably the safety profile of anti-malarial drugs. This study describes the implantation of a community-based pharmacovigilance system in Côte d’Ivoire and its use to document the safety of ASAQ Winthrop® (artesunate–amodiaquine). This prospective, longitudinal, descriptive, non-comparative, non-interventional study on the use of artesunate–amodiaquine in real-life conditions of use was conducted in seven Community Health Centres of the Agboville district in Côte d’Ivoire. Twenty trained Health Centre employees and 70 trained community health workers were involved in data collection in the field. All patients with suspected uncomplicated falciparum malaria, seeking treatment at one of the participating Health Centres, and treated with artesunate–amodiaquine could be enrolled. Two visits were planned, one for inclusion at the Health Centre and a second at home, performed by a community health worker 3–10 days after the inclusion visit. Administration of artesunate–amodiaquine was unsupervised. Adverse events (AEs) were documented at the home visit or during any unexpected visit to the Health Centre or to the hospital and coded and adjudicated by a local pharmacovigilance committee. Symptoms suggestive of hepatic failure, severe neutropaenia, extrapyramidal disorders and retinopathy were considered a priori as AEs of special interest. Some 15,228 malaria episodes in 12,198 patients were evaluated; 2545 AEs were documented during 1978 malaria episodes (13.0%). The most frequently observed events were asthenia (682 cases), vomiting (482 cases) and somnolence (174 cases). Most reported AEs were of mild or moderate intensity and resolved without corrective treatment. One-hundred and five (105) AEs reported during 100 episodes (0.7%) were considered as serious. Three serious cases of transient extrapyramidal disorders, identified as AEs of special interest were reported in three patients. The fixed dose artesunate–amodiaquine combination ASAQ Winthrop® for the unsupervised treatment of uncomplicated falciparum malaria under real-life conditions of care in Côte d’Ivoire is well tolerated. The study emphasizes the interest of involving properly trained community health workers to collect pharmacovigilance data in the field in order to document rare AEs.
- 3 January 2017
- Published by Springer Nature in Malaria Journal
- Vol. 16 (1) , 8
Open AccessSafety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d’Ivoire
In many malaria-endemic, sub-Saharan African countries, existing pharmacovigilance systems are not sufficiently operational to document reliably the safety profile of anti-malarial drugs. This study describes the implantation of a community-based pharmacovigilance system in Côte d’Ivoire and its use to document the safety of ASAQ Winthrop® (artesunate–amodiaquine). This prospective, longitudinal, descriptive, non-comparative, non-interventional study on the use of artesunate–amodiaquine in real-life conditions of use was conducted in seven Community Health Centres of the Agboville district in Côte d’Ivoire. Twenty trained Health Centre employees and 70 trained community health workers were involved in data collection in the field. All patients with suspected uncomplicated falciparum malaria, seeking treatment at one of the participating Health Centres, and treated with artesunate–amodiaquine could be enrolled. Two visits were planned, one for inclusion at the Health Centre and a second at home, performed by a community health worker 3–10 days after the inclusion visit. Administration of artesunate–amodiaquine was unsupervised. Adverse events (AEs) were documented at the home visit or during any unexpected visit to the Health Centre or to the hospital and coded and adjudicated by a local pharmacovigilance committee. Symptoms suggestive of hepatic failure, severe neutropaenia, extrapyramidal disorders and retinopathy were considered a priori as AEs of special interest. Some 15,228 malaria episodes in 12,198 patients were evaluated; 2545 AEs were documented during 1978 malaria episodes (13.0%). The most frequently observed events were asthenia (682 cases), vomiting (482 cases) and somnolence (174 cases). Most reported AEs were of mild or moderate intensity and resolved without corrective treatment. One-hundred and five (105) AEs reported during 100 episodes (0.7%) were considered as serious. Three serious cases of transient extrapyramidal disorders, identified as AEs of special interest were reported in three patients. The fixed dose artesunate–amodiaquine combination ASAQ Winthrop® for the unsupervised treatment of uncomplicated falciparum malaria under real-life conditions of care in Côte d’Ivoire is well tolerated. The study emphasizes the interest of involving properly trained community health workers to collect pharmacovigilance data in the field in order to document rare AEs.
- 13 May 2016
- Published by Lavoisier in Bulletin de la Société de pathologie exotique
- Vol. 109 (3) , 172-179
Morbidité et mortalité du tétanos des nouveau-nés et des enfants dans les Centres hospitaliers universitaires d’Abidjan, Côte d’Ivoire (2001-2010)
Résumé L’insuffisance de données sur le tétanos néonatal et de l’enfant dans les centres hospitaliers universitaires (CHU) d’Abidjan depuis plus d’une décennie a motivé la réalisation de cette étude. L’objectif de cette recherche est d’évaluer la morbi-mortalité liée au tétanos néonatal (TN) et au tétanos de l’enfant (TE) dans les CHU d’Abidjan de 2001 à 2010. Il s’agit d’une étude rétrospective, multi-service avec analyse des dossiers des nouveau-nés et enfants atteints de tétanos dans les trois CHU d’Abidjan. La saisie et l’analyse des données ont été faites par les logiciels SPHINX 4.5 et EPI.INFO 6.0. En dix ans, 242 cas de tétanos (53 cas de TN et 189 cas de TE) ont été colligés avec une prédominance des cas après la cinquième année de vie (59,5 %). Le taux d’incidence du TN était de moins de un cas pour 1 000 naissances vivantes. Les mères de nouveau-nés résidaient dans la ville d’Abidjan, leur âge médian était de 19 ans [16-32] et 64 % étaient adolescentes. Les portes d’entrée étaient dominées par les plaies ombilicales (77,3 %) dans le TN et les plaies cutanées (59 %) dans le TE. Le taux de guérison était de 30,2 % dans le TN et 60 % dans le TE. La létalité était de 60 % pour le TN et 22 % pour le TE, en lien significatif avec le jeune âge (nouveau-nés: p = 4.10-7, âge < 5 ans: p = 0,01), l’absence d’injection de SAT en intra-rachidien (p = 8.10-6), l’absence d’antibiothérapie classique (p = 0,023), l’existence de complications métaboliques (p = 2.10-5), le score de Dakar ≥ 4 (p = 0,005). Le tétanos demeure encore morbide en milieu pédiatrique dans les CHU d’Abidjan avec une létalité élevée. Cependant, l’incidence du TN en milieu abidjanais semble conforme au seuil d’incidence souhaité par l’OMS.
- 13 May 2016
- Published by Lavoisier in Bulletin de la Société de pathologie exotique
- Vol. 109 (3) , 172-179
Morbidité et mortalité du tétanos des nouveau-nés et des enfants dans les Centres hospitaliers universitaires d’Abidjan, Côte d’Ivoire (2001-2010)
Résumé L’insuffisance de données sur le tétanos néonatal et de l’enfant dans les centres hospitaliers universitaires (CHU) d’Abidjan depuis plus d’une décennie a motivé la réalisation de cette étude. L’objectif de cette recherche est d’évaluer la morbi-mortalité liée au tétanos néonatal (TN) et au tétanos de l’enfant (TE) dans les CHU d’Abidjan de 2001 à 2010. Il s’agit d’une étude rétrospective, multi-service avec analyse des dossiers des nouveau-nés et enfants atteints de tétanos dans les trois CHU d’Abidjan. La saisie et l’analyse des données ont été faites par les logiciels SPHINX 4.5 et EPI.INFO 6.0. En dix ans, 242 cas de tétanos (53 cas de TN et 189 cas de TE) ont été colligés avec une prédominance des cas après la cinquième année de vie (59,5 %). Le taux d’incidence du TN était de moins de un cas pour 1 000 naissances vivantes. Les mères de nouveau-nés résidaient dans la ville d’Abidjan, leur âge médian était de 19 ans [16-32] et 64 % étaient adolescentes. Les portes d’entrée étaient dominées par les plaies ombilicales (77,3 %) dans le TN et les plaies cutanées (59 %) dans le TE. Le taux de guérison était de 30,2 % dans le TN et 60 % dans le TE. La létalité était de 60 % pour le TN et 22 % pour le TE, en lien significatif avec le jeune âge (nouveau-nés: p = 4.10-7, âge < 5 ans: p = 0,01), l’absence d’injection de SAT en intra-rachidien (p = 8.10-6), l’absence d’antibiothérapie classique (p = 0,023), l’existence de complications métaboliques (p = 2.10-5), le score de Dakar ≥ 4 (p = 0,005). Le tétanos demeure encore morbide en milieu pédiatrique dans les CHU d’Abidjan avec une létalité élevée. Cependant, l’incidence du TN en milieu abidjanais semble conforme au seuil d’incidence souhaité par l’OMS.
- 1 July 2012
- Published by JLE in Medecine Et Sante Tropicales
- Vol. 22 (3) , 279-282
Surgical tetanus in Abidjan, Cote d’Ivoire
To describe the epidemiological and clinical features and the outcome of tetanus with a surgical wound (open fracture, burn, incision, curettage, etc) as the portal of entry. Cross-sectional analysis of records of patients hospitalized in the department of infectious and tropical diseases in Abidjan for surgical tetanus from 2003 to 2008. During the 6-year study period, 29 cases were identified. They accounted for 11% of all tetanus cases admitted to the hospital: 8% from 2003 through 2006 and 14% in 2007 and 2008. The patients' average age was 36 years (range: 11-72). Most cases (86%) involved recent surgery, in both public (51%) and private (49%) health facilities. All patients had generalized tetanus at admission, and 24 (86%) paroxysms. Moderate forms predominated (69%). The lethality of tetanus in these surgical wound cases was 45%. The characteristics statistically associated with death were: age >44 years, time of hospitalization >4 days, the presence of paroxysms, and a Dakar prognosis score ≥4. The severity of surgical tetanus remains a concern for practitioners. Its high prevalence in recent years demonstrates the need to increase surgeons' awareness of tetanus prevention.
- 1 July 2012
- Published by JLE in Medecine Et Sante Tropicales
- Vol. 22 (3) , 279-282
Surgical tetanus in Abidjan, Cote d’Ivoire
To describe the epidemiological and clinical features and the outcome of tetanus with a surgical wound (open fracture, burn, incision, curettage, etc) as the portal of entry. Cross-sectional analysis of records of patients hospitalized in the department of infectious and tropical diseases in Abidjan for surgical tetanus from 2003 to 2008. During the 6-year study period, 29 cases were identified. They accounted for 11% of all tetanus cases admitted to the hospital: 8% from 2003 through 2006 and 14% in 2007 and 2008. The patients' average age was 36 years (range: 11-72). Most cases (86%) involved recent surgery, in both public (51%) and private (49%) health facilities. All patients had generalized tetanus at admission, and 24 (86%) paroxysms. Moderate forms predominated (69%). The lethality of tetanus in these surgical wound cases was 45%. The characteristics statistically associated with death were: age >44 years, time of hospitalization >4 days, the presence of paroxysms, and a Dakar prognosis score ≥4. The severity of surgical tetanus remains a concern for practitioners. Its high prevalence in recent years demonstrates the need to increase surgeons' awareness of tetanus prevention.